Patent · US Active

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain

US8226978B2 · kind B2 · utility

25Cited by

3References

18Claims

0Family size

Assignee

AcelRx Pharmaceuticals, Inc. · US

Inventors

Pamela Palmer · San Francisco, US
Thomas Schreck · Portola Valley, US
Stelios Tzannis · Petaluma, US
Larry Hamel · Menlo Park, US
Andrew Poutiatine · Palo Alto, US
Charles Rampersaud · San Francisco, US
Bruce Edwards · Menlo Park, US

Key dates

Filing date	Dec 28, 2007
Grant date	Jul 24, 2012
Priority date	—
Expiry date	Jan 15, 2028

Classification

Technology area (CPC G)Physics
CPC primaryG07C9/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions, methods and systems for administration of small volume sufentanil-containing drug dosage forms to the oral mucosa of a subject are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.